Annual Revenue
$95.00 K
-$61.00 K-39.10%
31 December 2023
Summary:
Allogene Therapeutics annual revenue is currently $95.00 thousand, with the most recent change of -$61.00 thousand (-39.10%) on 31 December 2023. ALLO annual revenue is now -99.92% below its all-time high of $114.09 million, reached on 31 December 2021.ALLO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
30 September 2024
Summary:
Allogene Therapeutics quarterly revenue is not available.ALLO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
30 September 2024
Summary:
Allogene Therapeutics TTM revenue is not available.ALLO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.1% | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ALLO Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.9% | at low | ||||
| 5 y | 5 years | -99.9% | at low | ||||
| alltime | all time | -99.9% | at low |
Allogene Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $22.00 K(+4.8%) | $87.00 K(-8.4%) |
| Dec 2023 | $95.00 K(-39.1%) | $21.00 K(-4.5%) | $95.00 K(+179.4%) |
| Sept 2023 | - | $22.00 K(0.0%) | $34.00 K(-44.3%) |
| June 2023 | - | $22.00 K(-26.7%) | $61.00 K(-51.2%) |
| Mar 2023 | - | $30.00 K(-175.0%) | $125.00 K(-19.9%) |
| Dec 2022 | $156.00 K | -$40.00 K(-181.6%) | $156.00 K(-99.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $49.00 K(-43.0%) | $75.85 M(0.0%) |
| June 2022 | - | $86.00 K(+41.0%) | $75.85 M(+0.1%) |
| Mar 2022 | - | $61.00 K(-99.9%) | $75.81 M(-33.6%) |
| Dec 2021 | $114.09 M | $75.65 M(>+9900.0%) | $114.09 M(+196.8%) |
| Sept 2021 | - | $49.00 K(+11.4%) | $38.44 M(+0.1%) |
| June 2021 | - | $44.00 K(-99.9%) | $38.39 M(+0.1%) |
| Mar 2021 | - | $38.34 M | $38.34 M |
FAQ
- What is Allogene Therapeutics annual revenue?
- What is the all time high annual revenue for Allogene Therapeutics?
- What is Allogene Therapeutics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Allogene Therapeutics?
- What is the all time high TTM revenue for Allogene Therapeutics?
What is Allogene Therapeutics annual revenue?
The current annual revenue of ALLO is $95.00 K
What is the all time high annual revenue for Allogene Therapeutics?
Allogene Therapeutics all-time high annual revenue is $114.09 M
What is Allogene Therapeutics annual revenue year-on-year change?
Over the past year, ALLO annual revenue has changed by -$61.00 K (-39.10%)
What is the all time high quarterly revenue for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly revenue is $75.65 M
What is the all time high TTM revenue for Allogene Therapeutics?
Allogene Therapeutics all-time high TTM revenue is $114.09 M